1. Home
  2. FATE vs EBTC Comparison

FATE vs EBTC Comparison

Compare FATE & EBTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • EBTC
  • Stock Information
  • Founded
  • FATE 2007
  • EBTC 1989
  • Country
  • FATE United States
  • EBTC United States
  • Employees
  • FATE N/A
  • EBTC 570
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • EBTC Major Banks
  • Sector
  • FATE Health Care
  • EBTC Finance
  • Exchange
  • FATE Nasdaq
  • EBTC Nasdaq
  • Market Cap
  • FATE 406.5M
  • EBTC 455.5M
  • IPO Year
  • FATE 2013
  • EBTC 2005
  • Fundamental
  • Price
  • FATE $2.02
  • EBTC $36.65
  • Analyst Decision
  • FATE Buy
  • EBTC
  • Analyst Count
  • FATE 11
  • EBTC 0
  • Target Price
  • FATE $6.89
  • EBTC N/A
  • AVG Volume (30 Days)
  • FATE 1.6M
  • EBTC 17.5K
  • Earning Date
  • FATE 11-12-2024
  • EBTC 10-22-2024
  • Dividend Yield
  • FATE N/A
  • EBTC 2.62%
  • EPS Growth
  • FATE N/A
  • EBTC N/A
  • EPS
  • FATE N/A
  • EBTC 2.91
  • Revenue
  • FATE $13,447,000.00
  • EBTC $164,115,000.00
  • Revenue This Year
  • FATE N/A
  • EBTC N/A
  • Revenue Next Year
  • FATE N/A
  • EBTC N/A
  • P/E Ratio
  • FATE N/A
  • EBTC $12.60
  • Revenue Growth
  • FATE N/A
  • EBTC N/A
  • 52 Week Low
  • FATE $1.96
  • EBTC $22.60
  • 52 Week High
  • FATE $8.83
  • EBTC $39.37
  • Technical
  • Relative Strength Index (RSI)
  • FATE 31.10
  • EBTC 63.78
  • Support Level
  • FATE $2.33
  • EBTC $36.51
  • Resistance Level
  • FATE $2.58
  • EBTC $38.47
  • Average True Range (ATR)
  • FATE 0.25
  • EBTC 1.32
  • MACD
  • FATE -0.04
  • EBTC 0.29
  • Stochastic Oscillator
  • FATE 6.45
  • EBTC 66.50

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About EBTC Enterprise Bancorp Inc

Enterprise Bancorp Inc is a holding company engaged in the business of gathering deposits from the general public and investing in loans and investment securities. Through the Bank and its subsidiaries, the company offers a range of commercial, residential, and consumer loan products, deposit products, and cash management services, as well as wealth management and wealth services.

Share on Social Networks: